Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MTHRY BDULF BDUUF GIFLF SHPMY KYKOF ORINF SHPMF CHEOY ALBBY
6M 25.74 % -10.00 % -10.61 % 63.53 % 20.50 % 16.14 % 67.11 % -1.92 % 11.97 % 39.92 %
YTD 66.59 % -25.88 % -23.38 % 45.55 % -1.32 % 14.20 % 67.11 % -5.56 % 1.13 % 92.55 %
1Y 25.31 % -13.70 % -23.38 % 24.00 % 0.61 % -2.11 % 111.83 % -90.84 % -4.14 % 53.47 %
3Y -47.82 % -17.31 % -34.59 % 75.95 % 16.90 % -25.33 % 101.79 % -88.14 % 50.23 % 92.11 %
5Y -79.37 % -11.74 % -1.67 % -54.11 % 2.24 % -33.73 % 84.44 % -90.13 % 20.90 % -68.66 %
10Y -65.99 % 16.67 % -8.24 % -31.70 % -22.58 % 9.81 % 130.97 % -94.09 % 200.85 % -4.33 %
From the beginning -65.99 % 404.00 % 883.33 % -99.93 % -34.37 % 217.22 % 228.48 % -92.88 % 217.76 % -4.33 %

Dividend

M3, Inc.

Bangkok Dusit Medical Services Public Company Limited

Bangkok Dusit Medical Services Public Company Limited

Grifols, S.A.

Shanghai Pharmaceuticals Holding Co., Ltd

Kyowa Kirin Co., Ltd.

Orion Oyj

Shanghai Pharmaceuticals Holding Co., Ltd

Cochlear Limited